ADX Labs Partners with CEPI, Makes Donation Towards COVID-19 Vaccine Development
This June, in response to the COVID-19 pandemic, ADX, through our charitable arm the ADX Foundation, donated $100,000 to the Coalition for Epidemic Preparedness Innovations (CEPI) to speed the development of COVID-19 vaccines.
ADX Labs is committed to making a difference throughout the world through the power of technology. As a globally focused company, we aim to ensure our charitable giving supports causes both local and worldwide. The current outbreak of COVID-19 is a global struggle, and in our partnership with CEPI, we have found a like-minded organization built on innovation and dedicated to preparedness and vaccine equity. CEPI’s new Call for Proposals to accelerate vaccine candidates against COVID-19 is a highly promising initiative, and ADX Labs is proud to help CEPI’s vaccine development partners increase their chances of success.
CEPI, which multidisciplinary science journal Nature called “by far the largest vaccine development initiative ever against viruses that are potential epidemic threats,” has moved quickly to respond to the COVID-19 pandemic, and has funded a diverse portfolio of COVID-19 vaccine candidates, with the ambition of developing a safe, effective and globally accessible vaccine within a 12-18-month timeframe.
Dr. Richard Hatchett, CEO of CEPI, said, “We are incredibly grateful for ADX Labs’ donation to expedite our work to develop an effective vaccine against COVID-19. This global pandemic has resulted in a devastating loss of lives, while also fracturing societies and shutting down economies. Investment in vaccines and other scientific innovations now is crucial to give us the best possible chance of ending this pandemic. We are therefore delighted to welcome ADX to the coalition.”
About Coalition for Epidemic Preparedness Innovations (CEPI)
CEPI is an innovative partnership between public, private, philanthropic, and civil organizations to develop vaccines to stop future epidemics. Before COVID-19, CEPI’s priority diseases included Ebola, Lassa, Middle East Respiratory Syndrome, Nipah, Rift Valley Fever, Chikungunya and unknown pathogens (Disease X). Learn more at http://cepi.net